Schizophrenia thalamus imaging: low benzamide binding to dopamine D2 receptors suggests fewer D2Short receptors and fewer presynaptic terminals.

Seeman, Philip

Seeman, Philip.

Affiliation

Seeman P; Departments of Pharmacology and Psychiatry, University of Toronto, 260 Heath Street West, Unit 605, Toronto, Ont., Canada M5P 3L6. Electronic address: philip.seeman@utoronto.ca.

Psychiatry Res ; 214(3): 175-80, 2013 Dec 30.

Article in En | MEDLINE | ID: mdl-24120301

Subject(s)

Benzamides/metabolism; Presynaptic Terminals/metabolism; Receptors, Dopamine D2/chemistry; Receptors, Dopamine D2/metabolism; Schizophrenia/metabolism; Schizophrenia/pathology; Thalamus/metabolism; Dopamine/metabolism; Genetic Variation/genetics; Gyrus Cinguli/metabolism; Hippocampus/metabolism; Humans; Neostriatum/metabolism; Neuroimaging; Presynaptic Terminals/pathology; Receptors, Dopamine D2/analysis; Receptors, Dopamine D2/genetics; Schizophrenia/genetics; Thalamus/pathology

Key words

Antipsychotic; Brain imaging; Psychosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / Thalamus / Benzamides / Receptors, Dopamine D2 / Presynaptic Terminals Language: En Journal: Psychiatry Res Year: 2013 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google